Project 003 - VICI

NIH RePORTER · NIH · P01 · $334,748 · view on reporter.nih.gov ↗

Abstract

PROJECT 3. Viral, Immunologic and Cellular data Integration (VICI) Research Project - ABSTRACT For 40 years, research has advanced HIV medicine to the point where persons with HIV (PWH) can live normal and healthy lives if they have access to antiretroviral therapy (ART). Nevertheless, HIV cannot be readily cured. Curing HIV requires further advances in approaches to investigating biological systems at multiple scales, from interactions among genes within a cell to migration of HIV between tissues. Innovative methods are needed to characterize HIV dynamics more fully in settings where ART is and is not stopped. These methods are urgently needed to address the challenges that arise in proof-of-concept studies with a small number of participants. The VICI Research Project (RP) proposes development and validation of methods for analyzing large and complex datasets generated by the other RPs (VENI and VIDI) from 20 well-characterize participants enrolled in the innovative Last Gift cohort. As reproducible scientific results depend as much on development of novel analytical methods to address the challenges posed by these datasets as on their generation, we propose to devote considerable resources and talent to the proposed VICI RP. Throughout this VICI RP, we describe development, statistical validation, and application of models that integrate high-dimensional, single-cell and single-genome data with clinical and other low-dimensional covariates. Proposed methods use a ‘systems’ approach that incorporates connections among complex and distinct entities (e.g., gene expression, integration site, epigenetic marks, tissue types) or elucidates relationships among predictors to integrate the totality of the data. Aims 1 and 2 focus on novel statistical methods to (1) combine novel network methods with the discrete trait analyses (described in the VENI RP) to infer viral migration networks and its predictors, and (2) identify cell phenotypes based on classes of gene regulatory networks identified through a novel form of recursive partitioning. These methods will be directly applied to analyze HIV activation and repopulation of tissues. Aim 3 uses mediation analysis⸺including novel tests for heterogeneity in mediation effects⸺to assess mechanisms that drive HIV persistence in the body. These complementary aims share the same overarching goal of providing a system-based framework that facilitates analysis of large, complex, and high dimensional datasets. To illustrate the study framework and guide reviewers, we describe the application of the proposed innovative methods on the study-defined reservoir states of HIV leaving, coming, and staying HOME on and off ART.

Key facts

NIH application ID
10602745
Project number
5P01AI169609-02
Recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Principal Investigator
VICTOR GERARD DEGRUTTOLA
Activity code
P01
Funding institute
NIH
Fiscal year
2023
Award amount
$334,748
Award type
5
Project period
2022-04-01 → 2027-03-31